BUZZ-Teladoc climbs on Lilly tie up to offer Zepbound

Reuters03-06

** Telehealth firm Teladoc Health's TDOC.N shares rise 3.5% to $9.35 premarket

** Teladoc Health and LifeMD LFMD.O say they have tied up with Gifthealth, the pharmacy partner of Eli Lilly's LLY.N direct-to-consumer website LillyDirect, to offer patients the weight-loss drug Zepbound

** Tie-up allows eligible members to gain access to single-use vials that can be delivered directly to their home

** Last week, Lilly began selling higher doses of Zepbound in vials in the U.S. at a $150 discount to the cost of the injector pen versions

** TDOC has fallen 37.5% in the past 12 months

(Reporting by Siddhi Mahatole)

((siddhi.mahatole@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment